-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – volixibat potassium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry volixibat potassium Drug Details Volixibat potassium (SHP-626, LUM-002) is under development for adult cholestasis...
-
Product Insights
Heywood Solar PV Park
Heywood solar PV Park is a 80MW solar PV power project located in Victoria, Australia. It is being developed by AusNet Services Ltd; Countrywide Renewable Energy Pty Ltd. The project is currently in the announced stage. The project is expected to enter commercial operation in 2025. The project is owned by AusNet Services Ltd; Commonwealth Scientific and Industrial Research Organisation; Countrywide Renewable Energy Pty Ltd; Deakin University; Glenelg Shire Council; ITM Power Pty Ltd. Heywood solar PV Park profile includes...
-
Product Insights
Retinopathy of Prematurity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinopathy Of Prematurity – Drugs In Development, 2022, provides an overview of the Retinopathy Of Prematurity (Ophthalmology) pipeline landscape. Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies. This disorder which usually develops in both eyes is one of the most common causes of visual loss in childhood and can lead to lifelong vision impairment and blindness Risk factors for the development...
-
Sector Analysis
Global Oil Storage Industry Outlook to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
Global Oil Storage Industry Outlook to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report providing information on storage terminals that store crude oil, petroleum products and chemicals worldwide. The report provides terminal name, operator name, commodity stored and storage capacity for all active, planned, announced, suspended, and decommissioned oil storage terminals in the world by region and country for the period 2012–2022. Planned and announced (new build) storage terminals...
-
Sector Analysis
Global Planned Oil Storage Industry Outlook to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Planned Terminals
Global Planned Oil Storage Industry Outlook to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Planned Terminals is a comprehensive report providing information on planned storage terminals that store crude oil, petroleum products and chemicals worldwide. The report provides terminal name, operator name, storage capacity and commodity stored for all planned and announced terminals in the world by region and country for the period 2018–2022. The report also provides global and regional capital expenditure outlook by key...
-
Product Insights
Myeloproliferative Disorders Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Myeloproliferative Disorders Global Clinical Trials Review, H1, 2018" provides an overview of Myeloproliferative Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Myeloproliferative Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Otitis Externa Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Otitis Externa Global Clinical Trials Review, H1, 2018" provides an overview of Otitis Externa clinical trials scenario. This report provides top line data relating to the clinical trials on Otitis Externa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Neuromyelitis Optica (Devic’s Syndrome) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neuromyelitis Optica (Devic’s Syndrome) Global Clinical Trials Review, H1, 2018" provides an overview of Neuromyelitis Optica (Devic’s Syndrome) clinical trials scenario. This report provides top line data relating to the clinical trials on Neuromyelitis Optica (Devic’s Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H1, 2018" provides an overview of Oppositional Defiant Disorder (ODD) clinical trials scenario. This report provides top line data relating to the clinical trials on Oppositional Defiant Disorder (ODD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...